NTLA : Intellia Therapeutics stock forecast, predictions, and share price target 2025 - 2026 - 2030 - 2035 with analysis
| year | Average | Low | High | Change from close on 2025-04-23 |
|---|---|---|---|---|
| 2025 | $11.02 | $8.84 | $11.73 | 33.92% |
| 2026 | $10.5 | $6.7 | $11.54 | 27.59% |
| 2027 | $9.74 | $6.5 | $13.72 | 18.4% |
| 2028 | $11.7 | $7.07 | $13.7 | 42.19% |
| 2029 | $9.92 | $7.17 | $13.58 | 20.5% |
| 2030 | $12.36 | $8.15 | $13.91 | 50.18% |
| 2031 | $9.52 | $7.25 | $12.58 | 15.65% |
| 2032 | $12.81 | $11.08 | $13.72 | 55.73% |
| 2033 | $9.09 | $7.16 | $11.35 | 10.41% |
| 2034 | $12.95 | $12.15 | $13.74 | 57.4% |
| 2035 | $8.67 | $7.1 | $11.14 | 5.31% |
The 23 Wall Street analysts offering Intellia Therapeutics stock forecast in the last 6 months have average price target of
$42.17 with a high forecast of $91.0 and a low forecast of $11.0.
The average Intellia Therapeutics stock forecast represents a 412.46%
increase from the last price of $8.229000091552734.
For Intellia Therapeutics stock forecast for 2025, 8 predictions are offered for each month of 2025 with average Intellia Therapeutics stock
forecast of $11.02, a high forecast of $11.73, and a low forecast of $8.84.
The average Intellia Therapeutics stock forecast 2025 represents a 33.92%
increase from the last price of $8.229000091552734.
For Intellia Therapeutics stock forecast for 2026, 12 predictions are offered for each month of 2026 with average Intellia Therapeutics stock
forecast of $10.5, a high forecast of $11.54, and a low forecast of $6.7.
The average Intellia Therapeutics stock forecast 2026 represents a 27.59%
increase from the last price of $8.229000091552734.
For Intellia Therapeutics stock forecast for 2028, 12 predictions are offered for each month of 2028 with average Intellia Therapeutics stock
forecast of $11.7, a high forecast of $13.7, and a low forecast of $7.07.
The average Intellia Therapeutics stock forecast 2028 represents a 42.19%
increase from the last price of $8.229000091552734.
For Intellia Therapeutics stock forecast for 2030 (5 year), 12 predictions are offered for each month of 2030 with average Intellia Therapeutics stock
forecast of $12.36, a high forecast of $13.91, and a low forecast of $8.15.
The average Intellia Therapeutics stock forecast 2030 represents a 50.18%
increase from the last price of $8.229000091552734.
For Intellia Therapeutics stock forecast 2031, 12 predictions are offered for each month of 2031 with average Intellia Therapeutics stock
forecast of $9.52, a high forecast of $12.58, and a low forecast of $7.25.
The average Intellia Therapeutics stock forecast 2031 represents a 15.65%
increase from the last price of $8.229000091552734.
For Intellia Therapeutics stock forecast for 2035 (10 year), 4 predictions are offered for each month of 2035 with average Intellia Therapeutics stock
forecast of $8.67, a high forecast of $11.14, and a low forecast of $7.1.
The average Intellia Therapeutics stock forecast 2035 represents a 5.31%
increase from the last price of $8.229000091552734.
Please, see more forecasts below.
NTLA : Intellia Therapeutics stock forecast by Wall Street Analysts
The average Intellia Therapeutics stock forecast from last 6 month is $42.17, and this show a -24.68% decrease in average from the prior price target of the each prediction. Also, this average forecast of $42.17 represents a -30.08% decrease from the past average forecast of $60.31, 6 months ago from 13 wall street analysts.
| Date | Firm | previous price target | current price target | current rating |
|---|---|---|---|---|
| 2025-04-21 | Wolfe Research | $21.0000 | Outperform | |
| 2025-03-05 | HC Wainwright & Co. | $30 | Buy | |
| 2025-03-04 | Truist Securities | $90.0000 | $50 | Buy |
| 2025-02-28 | JP Morgan | $45.0000 | $13.0000 | Neutral |
| 2025-02-28 | Chardan Capital | $91.00 | $68.0000 | Buy |
| 2025-02-28 | Wells Fargo | $60.00 | $50.0000 | Overweight |
| 2025-02-28 | Citigroup | $12.0000 | $14.0000 | Neutral |
| 2025-02-28 | Barclays | $55.00 | $26.0000 | Overweight |
| 2025-01-27 | Morgan Stanley | $56.0000 | $11.0000 | Equal-Weight |
| 2025-01-14 | Goldman Sachs | $19.0000 | $12 | Neutral |
| 2025-01-13 | Oppenheimer | $60.00 | $40 | Outperform |
| 2025-01-10 | BMO Capital | $70.00 | $50 | Outperform |
| 2025-01-10 | Wells Fargo | $70.00 | $60.0000 | Overweight |
| 2024-11-19 | Canaccord Genuity | $90.0000 | $90.0000 | Buy |
| 2024-11-18 | Chardan Capital | $88.0000 | $91.0000 | Buy |
| 2024-11-18 | Wedbush | $14.0000 | $14 | Neutral |
| 2024-11-18 | Wells Fargo | $80.0000 | $70.0000 | Overweight |
| 2024-11-11 | Oppenheimer | $70.00 | $60 | Outperform |
| 2024-11-08 | Barclays | $76.0000 | $55.0000 | Overweight |
| 2024-10-25 | Baird | $24.0000 | $18 | Neutral |
| 2024-10-25 | Goldman Sachs | $31.0000 | $20 | Neutral |
| 2024-10-25 | Citigroup | $25.0000 | $19.0000 | Neutral |
| 2024-10-24 | Chardan Capital | $94.0000 | $88 | Buy |
| 2024-09-19 | RBC Capital | $54.00 | $54.00 | Outperform |
| 2024-09-17 | Jones Trading | $41.0000 | Buy | |
| 2024-09-11 | Stifel | $80.0000 | $64 | Buy |
| 2024-08-12 | JP Morgan | $61.0000 | $55.0000 | Overweight |
| 2024-08-09 | RBC Capital | $60.0000 | $54 | Outperform |
| 2024-06-27 | Canaccord Genuity | $73.00 | $73.0000 | Buy |
| 2024-06-24 | Truist Securities | $120.0000 | $120 | Buy |
| 2024-06-24 | Cantor Fitzgerald | $65.00 | $65.0000 | Overweight |
| 2024-06-18 | Cantor Fitzgerald | $65.00 | $65.0000 | Overweight |
| 2024-06-04 | Cantor Fitzgerald | $65.00 | $65.00 | Overweight |
| 2024-05-10 | BMO Capital | $62.00 | $70 | Outperform |
| 2024-05-10 | Citigroup | $31.0000 | $29.0000 | Neutral |
| 2024-04-23 | Wedbush | $29.0000 | Neutral |
Intellia Therapeutics stock forecast for upcoming days
| Date | Price Target | Change |
|---|---|---|
| 2025-04-24 | $7.91 | -3.89% |
| 2025-04-25 | $7.77 | -1.71% |
| 2025-04-28 | $7.74 | -0.44% |
| 2025-04-29 | $7.72 | -0.21% |
| 2025-04-30 | $7.68 | -0.51% |
NTLA : Long term Intellia Therapeutics stock forecast for 2025 - 2026 - 2030 - 2035
Forecast for 2025 May. is $8.84 , for 2026 Apr. is $11.34 , for 2029 Apr. is $8.97 , for 2030 Apr. is $13.35 , for 2034 Apr. is $13.69 , and for 2035 Apr. is $7.10.
NTLA : Intellia Therapeutics stock forecast for 2025
| Date | Price Target | Change |
|---|---|---|
| 2025 May. | $8.84 | 7.45% |
| 2025 Jun. | $10.05 | 13.67% |
| 2025 Jul. | $11.01 | 9.56% |
| 2025 Aug. | $11.53 | 4.74% |
| 2025 Sep. | $11.72 | 1.64% |
| 2025 Oct. | $11.73 | 0.07% |
| 2025 Nov. | $11.67 | -0.54% |
| 2025 Dec. | $11.60 | -0.62% |
NTLA : Intellia Therapeutics stock forecast for 2026
| Date | Price Target | Change |
|---|---|---|
| 2026 Jan. | $11.54 | -0.48% |
| 2026 Feb. | $11.48 | -0.56% |
| 2026 Mar. | $11.41 | -0.57% |
| 2026 Apr. | $11.34 | -0.59% |
| 2026 May. | $11.28 | -0.55% |
| 2026 Jun. | $11.20 | -0.70% |
| 2026 Jul. | $11.10 | -0.91% |
| 2026 Aug. | $11.04 | -0.55% |
| 2026 Sep. | $10.90 | -1.27% |
| 2026 Oct. | $10.01 | -8.15% |
| 2026 Nov. | $7.99 | -20.14% |
| 2026 Dec. | $6.70 | -16.20% |
NTLA : Intellia Therapeutics stock forecast for 2027
| Date | Price Target | Change |
|---|---|---|
| 2027 Jan. | $6.50 | -2.98% |
| 2027 Feb. | $6.95 | 6.97% |
| 2027 Mar. | $7.60 | 9.38% |
| 2027 Apr. | $8.22 | 8.13% |
| 2027 May. | $8.71 | 5.96% |
| 2027 Jun. | $9.09 | 4.32% |
| 2027 Jul. | $9.46 | 4.13% |
| 2027 Aug. | $10.10 | 6.67% |
| 2027 Sep. | $10.87 | 7.67% |
| 2027 Oct. | $12.31 | 13.27% |
| 2027 Nov. | $13.38 | 8.64% |
| 2027 Dec. | $13.72 | 2.60% |
NTLA : Intellia Therapeutics stock forecast for 2028
| Date | Price Target | Change |
|---|---|---|
| 2028 Jan. | $13.70 | -0.15% |
| 2028 Feb. | $13.50 | -1.49% |
| 2028 Mar. | $13.23 | -2.02% |
| 2028 Apr. | $12.95 | -2.08% |
| 2028 May. | $12.72 | -1.82% |
| 2028 Jun. | $12.53 | -1.45% |
| 2028 Jul. | $12.36 | -1.36% |
| 2028 Aug. | $12.23 | -1.07% |
| 2028 Sep. | $11.90 | -2.71% |
| 2028 Oct. | $10.16 | -14.64% |
| 2028 Nov. | $8.07 | -20.58% |
| 2028 Dec. | $7.07 | -12.31% |
NTLA : Intellia Therapeutics stock forecast for 2029
| Date | Price Target | Change |
|---|---|---|
| 2029 Jan. | $7.17 | 1.44% |
| 2029 Feb. | $7.79 | 8.64% |
| 2029 Mar. | $8.46 | 8.50% |
| 2029 Apr. | $8.97 | 6.05% |
| 2029 May. | $9.31 | 3.83% |
| 2029 Jun. | $9.53 | 2.37% |
| 2029 Jul. | $9.71 | 1.85% |
| 2029 Aug. | $10.01 | 3.14% |
| 2029 Sep. | $10.59 | 5.81% |
| 2029 Oct. | $11.24 | 6.10% |
| 2029 Nov. | $12.62 | 12.27% |
| 2029 Dec. | $13.58 | 7.65% |
NTLA : Intellia Therapeutics stock forecast for 2030
| Date | Price Target | Change |
|---|---|---|
| 2030 Jan. | $13.91 | 2.39% |
| 2030 Feb. | $13.85 | -0.42% |
| 2030 Mar. | $13.70 | -1.10% |
| 2030 Apr. | $13.35 | -2.52% |
| 2030 May. | $13.05 | -2.30% |
| 2030 Jun. | $12.81 | -1.84% |
| 2030 Jul. | $12.62 | -1.42% |
| 2030 Aug. | $12.46 | -1.31% |
| 2030 Sep. | $12.36 | -0.80% |
| 2030 Oct. | $11.90 | -3.75% |
| 2030 Nov. | $10.15 | -14.69% |
| 2030 Dec. | $8.15 | -19.67% |
NTLA : Intellia Therapeutics stock forecast for 2031
| Date | Price Target | Change |
|---|---|---|
| 2031 Jan. | $7.25 | -11.00% |
| 2031 Feb. | $7.40 | 1.99% |
| 2031 Mar. | $8.00 | 8.13% |
| 2031 Apr. | $8.63 | 7.91% |
| 2031 May. | $9.11 | 5.55% |
| 2031 Jun. | $9.43 | 3.54% |
| 2031 Jul. | $9.65 | 2.32% |
| 2031 Aug. | $9.85 | 2.04% |
| 2031 Sep. | $10.23 | 3.82% |
| 2031 Oct. | $10.74 | 5.03% |
| 2031 Nov. | $11.31 | 5.29% |
| 2031 Dec. | $12.58 | 11.25% |
NTLA : Intellia Therapeutics stock forecast for 2032
| Date | Price Target | Change |
|---|---|---|
| 2032 Jan. | $13.44 | 6.81% |
| 2032 Feb. | $13.72 | 2.05% |
| 2032 Mar. | $13.65 | -0.47% |
| 2032 Apr. | $13.50 | -1.14% |
| 2032 May. | $13.19 | -2.28% |
| 2032 Jun. | $12.92 | -2.04% |
| 2032 Jul. | $12.72 | -1.51% |
| 2032 Aug. | $12.58 | -1.13% |
| 2032 Sep. | $12.45 | -1.04% |
| 2032 Oct. | $12.37 | -0.66% |
| 2032 Nov. | $12.17 | -1.62% |
| 2032 Dec. | $11.08 | -8.95% |
NTLA : Intellia Therapeutics stock forecast for 2033
| Date | Price Target | Change |
|---|---|---|
| 2033 Jan. | $8.97 | -19.05% |
| 2033 Feb. | $7.49 | -16.51% |
| 2033 Mar. | $7.16 | -4.41% |
| 2033 Apr. | $7.59 | 6.05% |
| 2033 May. | $8.27 | 8.93% |
| 2033 Jun. | $8.85 | 7.08% |
| 2033 Jul. | $9.27 | 4.72% |
| 2033 Aug. | $9.55 | 3.02% |
| 2033 Sep. | $9.76 | 2.15% |
| 2033 Oct. | $10.10 | 3.49% |
| 2033 Nov. | $10.68 | 5.80% |
| 2033 Dec. | $11.35 | 6.21% |
NTLA : Intellia Therapeutics stock forecast for 2034
| Date | Price Target | Change |
|---|---|---|
| 2034 Jan. | $12.63 | 11.31% |
| 2034 Feb. | $13.47 | 6.68% |
| 2034 Mar. | $13.74 | 1.99% |
| 2034 Apr. | $13.69 | -0.36% |
| 2034 May. | $13.53 | -1.22% |
| 2034 Jun. | $13.20 | -2.37% |
| 2034 Jul. | $12.93 | -2.04% |
| 2034 Aug. | $12.73 | -1.59% |
| 2034 Sep. | $12.58 | -1.17% |
| 2034 Oct. | $12.44 | -1.11% |
| 2034 Nov. | $12.33 | -0.86% |
| 2034 Dec. | $12.15 | -1.51% |
NTLA : Intellia Therapeutics stock forecast for 2035
| Date | Price Target | Change |
|---|---|---|
| 2035 Jan. | $11.14 | -8.33% |
| 2035 Feb. | $8.97 | -19.45% |
| 2035 Mar. | $7.46 | -16.85% |
| 2035 Apr. | $7.10 | -4.80% |
Financial Data for Intellia Therapeutics stock
Frequently Asked Questions about Intellia Therapeutics stock forecast
Is Intellia Therapeutics a good long term stock?
From Intellia Therapeutics stock forecast , Intellia Therapeutics (NTLA) stock can be a good investment choice. According to AIPickup, the Intellia Therapeutics stock price forecast for 2025 May. is $8.842249679387763 From Intellia Therapeutics stock forecast , Intellia Therapeutics (NTLA) stock can be a good investment choice. According to AIPickup, the Intellia Therapeutics stock price forecast for 2026 Apr. is $11.343324650881597 From Intellia Therapeutics stock forecast , Intellia Therapeutics (NTLA) stock can be a good investment choice. According to AIPickup, the Intellia Therapeutics stock price forecast for 2029 Apr. is $8.967245299154047 From Intellia Therapeutics stock forecast , Intellia Therapeutics (NTLA) stock can be a good investment choice. According to AIPickup, the Intellia Therapeutics stock price forecast for 2030 Apr. is $13.352668703702538 From Intellia Therapeutics stock forecast , Intellia Therapeutics (NTLA) stock can be a good investment choice. According to AIPickup, the Intellia Therapeutics stock price forecast for 2034 Apr. is $13.691791740826341 From Intellia Therapeutics stock forecast , Intellia Therapeutics (NTLA) stock cannot be a good investment choice. According to AIPickup, the Intellia Therapeutics stock price forecast for 2035 Apr. is $7.1006602826804786
Is Intellia Therapeutics stock overvalued?
Intellia Therapeutics (NTLA) stock is expected to go UP . Therefore, AIPickup would say that Intellia Therapeutics (NTLA) stock is NOT overvalued.
Will Intellia Therapeutics stock price go up?
Yes. The Intellia Therapeutics stock price forecast for 2026 Apr. is $11.343324650881597
Is Intellia Therapeutics stock a good buy now?
Since closing price on 2025-04-23 is $8.229000091552734 and forecast for 2026 Apr. is $11.34, Intellia Therapeutics stock is a good 1 year investment.
14 Days Historical Data for Intellia Therapeutics stock price
| Date | Close | Open | Low | High |
|---|---|---|---|---|
| NTLA stock price for 2025-04-03 | $6.89 | $6.87 | $6.77 | $7.21 |
| NTLA stock price for 2025-04-04 | $6.63 | $6.83 | $6.43 | $6.91 |
| NTLA stock price for 2025-04-07 | $6.54 | $6.19 | $5.90 | $6.88 |
| NTLA stock price for 2025-04-08 | $6.28 | $6.87 | $6.12 | $7.03 |
| NTLA stock price for 2025-04-09 | $7.08 | $6.10 | $5.97 | $7.38 |
| NTLA stock price for 2025-04-10 | $6.77 | $6.79 | $6.36 | $6.91 |
| NTLA stock price for 2025-04-11 | $7.41 | $6.74 | $6.65 | $7.44 |
| NTLA stock price for 2025-04-14 | $7.50 | $7.56 | $7.26 | $7.67 |
| NTLA stock price for 2025-04-15 | $7.36 | $7.36 | $7.24 | $7.76 |
| NTLA stock price for 2025-04-16 | $6.86 | $7.20 | $6.73 | $7.27 |
| NTLA stock price for 2025-04-17 | $7.23 | $6.85 | $6.80 | $7.30 |
| NTLA stock price for 2025-04-21 | $7.92 | $7.36 | $7.15 | $8.33 |
| NTLA stock price for 2025-04-22 | $8.31 | $7.94 | $7.86 | $8.33 |
| NTLA stock price for 2025-04-23 | $8.23 | $8.67 | $8.22 | $8.90 |